UF Neuroscience Expert Dr. Eduardo Candelario-Jalil Appointed on Emerald Health Pharmaceuticals Scientific Advisory Board
Emerald Health Pharmaceuticals Inc., a clinical-stage biotechnology company developing a new class of medicines to treat diseases with unmet medical needs, has expanded its Scientific Advisory Board with the appointment of University of Florida‘s neuroscience expert and innovator, Eduardo Candelario-Jalil, Ph.D.
“We are honored to have Dr. Candelario-Jalil join our Scientific Advisory Board as we advance our research and clinical programs,” said Eduardo Muñoz, MD, Ph.D., chief scientific officer of EHP. “His expertise and innovative work in neuroinflammatory mechanisms add greatly to our outstanding team of world-class scientific experts, which includes Professor Giovanni Appendino, Ph.D., a key opinion leader in chemistry, and Rao Movva, Ph.D., a Novartis Distinguished Scientist.”
Learn more about UF Neuroscience Expert Dr. Eduardo Candelario-Jalil Appointed on Emerald Health Pharmaceuticals Scientific Advisory Board.